source
- AI-driven biotech Enveda secures $311 million Series E to advance plant-derived drug candidatesEnveda Biosciences, a Colorado AI drug discovery company, announced a $311 million Series E financing round, one of the larger biotech raises this year. The firm uses artificial intelligence to sc…
- Flagship Pioneering secures Pentagon contract to develop biological threat countermeasuresFlagship Pioneering, a biotech investment firm, has been awarded a contract by the U.S. Department of Defense. The contract aims to advance technologies that can serve as countermeasures against b…